Acute myeloid leukemia with multilineage dysplasia
Information
- Disease name
- Acute myeloid leukemia with multilineage dysplasia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02658487 | Active, not recruiting | Phase 2 | Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia | March 2016 | September 2024 |
| NCT01567059 | Completed | Phase 2 | Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome | May 2012 | June 2013 |
| NCT03047993 | Completed | Phase 1/Phase 2 | Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome | November 15, 2017 | March 16, 2023 |
| NCT04802161 | Recruiting | Phase 2 | Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes | August 24, 2022 | December 31, 2024 |
| NCT04869683 | Recruiting | N/A | Biocollection in MyeloDysplastic Syndrome (P-MDS) | October 19, 2022 | October 19, 2032 |
| NCT01028716 | Terminated | Phase 2 | Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies | May 19, 2010 | October 7, 2021 |